Global Edition news

By Dave Muoio February 20, 2019
A survey of 164 US adults published last week in npj Digital Medicine suggests that while many individuals seeking psychotherapy for depression would consider a digital treatment with or without supplementary support, a one-on-one in-person visit is still the most popular option due to concerns of efficacy, access and confidentiality. Topline data Forty-nine percent of the survey’s eligible...
By Laura Lovett February 20, 2019
Looking to innovate in the research space, pharma giant Pfizer inked a deal with Ochsner Health System, a Louisiana academic healthcare system, to develop digital tools for clinical trials. The partners will be using Ochsner’s innovation lab, innovationOchsner, and Ochsner Research.  The multi-year strategic alliance revolves around a goal of improving “access and connectivity to clinical trials...
Novo Nordisk insulin pens
By Jonah Comstock February 20, 2019
Novo Nordisk’s connected insulin pens will integrate with the Abbott Freestyle Libre system, allowing Freestyle Libre users to see data about their insulin alongside their glucose readings, the companies announced this morning. "Lack of reliable information is a cause of huge frustration for many people with diabetes and their doctors," Anders Dyhr Toft, CVP of commercial innovation at Novo...

Photo by Monty Rakusen (Getty).

By Jonah Comstock February 19, 2019
Clinical data analysis company Covera Health has raised $8.5 million in a Series A funding round led by Equity Group Investments (EGI). Additional undisclosed strategic and individual investors also contributed to the round. This is Covera’s first round of institutional funding. What they do Covera Health uses data analytics to help its payer and employer customers choose the best providers and...
By Dave Muoio February 19, 2019
Last week the FDA granted its first marketing authorization to an interoperable insulin pump that is compatible with automated insulin dosing systems, continuous glucose monitors, blood glucose meters and other diabetes therapy devices built by different manufacturers. The Tandem Diabetes Care t:Slim X2 insulin pump was reviewed through the De Novo premarket review pathway, making it the first of...
By Laura Lovett February 19, 2019
Last week Vicarious Surgical, a Cambridge, Massachusetts-based startup that combines virtual reality with surgical robotics, announced that it closed a $10 million funding round. Gates Frontier led the round with participation from Khosla Ventures, Innovation Endeavors, AME Cloud Ventures and Marc Benioff.  What they do  The company said that by using its VR and surgical robotic technology,...

Verisense by Shimmer IMU (Photo courtesy Shimmer)

By Jonah Comstock February 19, 2019
Shimmer, a Dublin-based wearable sensor company, has launched a new sensor platform for clinical trials called VeriSense. At launch, the platform will work with Shimmer's IMU, or inertial measurement unit, sensor, which can measure activity and sleep from the wrist, as well as network with sensors elsewhere on the body to monitor musculoskeletal and neurological conditions. The company has been...
By Laura Lovett February 19, 2019
As the adoption of digital health continues to climb among consumers, how customers are using that technology is evolving. Instead of a narrow focus on general health and fitness, users are starting to employ digital health to manage complex conditions, according to a recent Rock Health study.  “Consumers continue to go digital and are now doing so not just out of curiosity or for general fitness...
By Dave Muoio February 19, 2019
Emedgene, a startup that employs artificial intelligence to interpret genetic data, has closed a $6 million round led by OliveTree Ventures. What they do Trained using data from patient cases, publications and genomics databases, Emedgene’s decision support engine can identify and highlight clinically relevant genetic variants for the provider. The platform is supported by a digital workbench...
By Laura Lovett February 18, 2019
This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected pens are expected to launch in early 2019, and will include Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus. As part of today’s announcement Glooko also revealed a new compatibility feature for the ...

Editor's Pick